An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Titan Medical to Present at the Bloom Burton & Co. Healthcare Investor Conference
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Titan Medical Inc. (NASDAQ: TMDI), a company specializing in robotic-assisted surgery, will present its Enos™ system at the Bloom Burton & Co. Healthcare Investor Conference on May 2-3, 2022, in Toronto. Interim President and CEO, Paul Cataford, along with CFO Stephen Lemieux, will provide insights and engage in investor meetings. The presentation is scheduled for May 2 at 3:30 PM ET and will be available via live webcast on the company's website. Titan is focused on enhancing surgical innovation and initially targeting gynecologic surgical applications.
Positive
None.
Negative
None.
TORONTO--(BUSINESS WIRE)--
Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical technology company focused on single access robotic-assisted surgery (RAS) system, today announced the company will present an overview of its Enos™ robotic single access surgical system at the Bloom Burton & Co.Healthcare Investor Conference, taking place May 2-3, 2022 at the Metro Toronto Convention Center.
Paul Cataford, Titan’s interim President and CEO, will provide a company overview and participate in investor meetings with Stephen Lemieux, Titan’s CFO.
Titan Medical’s presentation is scheduled for Monday, May 2nd at 3:30 pm ET. The presentation will be available via live webcast and replay on the Investor Relations Events section of the company’s website https://ir.titanmedicalinc.com/news-events/ir-calendar.
About Titan Medical
Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company headquartered in Toronto, Ontario and with operations in Chapel Hill, North Carolina, is focused on enhancing robotic assisted surgery using innovative technology through a single access point. The Enos™ robotic single access surgical system is being developed with an ergonomic focus to provide a surgical experience that imitates real-life movements that surgeons demand and includes multi-articulating instruments designed to allow surgeons an increased range of motion in a confined space, with dexterity and the ability to exert the forces necessary to complete common surgical tasks. With the Enos system, Titan intends to initially pursue gynecologic surgical indications.
This news release contains “forward-looking statements” within the meaning of applicable Canadian and U.S. securities laws, which reflect the current expectations of management of the company’s future growth, results of operations, performance and business prospects and opportunities. Forward-looking statements are frequently, but not always, identified by words such as “may”, “would”, “could”, “will”, “anticipate”, “believe”, “plan”, “expect”, “intend”, “estimate”, “potential for” and similar expressions, although these words may not be present in all forward-looking statements. Forward-looking statements that appear in this release may include, without limitation, references to: the company’s focus on the design and development of surgical technologies for robotic single access surgery; the Enos system providing a surgical experience that imitates real-life movements; the company’s intention to initially pursue gynecologic surgical indications with the Enos system. These statements reflect management’s current beliefs with respect to future events and are based on information currently available to management. Forward-looking statements involve significant risks, uncertainties and assumptions. Many factors could cause the company’s actual results, performance or achievements to be materially different from any future results, performance or achievements that may be expressed or implied by such forward-looking statements, including, without limitation, those listed in the “Risk Factors” section of the company’s Annual Report for the fiscal year ended December 31, 2021 (which may be viewed at www.sedar.com and at www.sec.gov). Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking statements prove incorrect, actual results, performance, or achievements may vary materially from those expressed or implied by the forward-looking statements contained in this news release. These factors should be considered carefully, and prospective investors should not place undue reliance on the forward-looking statements. Although the forward-looking statements contained in the news release are based upon what management currently believes to be reasonable assumptions, the company cannot assure prospective investors that actual results, performance or achievements will be consistent with these forward-looking statements. Except as required by law, the company expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.
What is the TMDI presentation at the Bloom Burton & Co. Healthcare Investor Conference?
Titan Medical Inc. (NASDAQ: TMDI) will present its Enos™ robotic surgical system on May 2, 2022, during the Bloom Burton & Co. Healthcare Investor Conference.
Who will represent TMDI at the Healthcare Investor Conference?
Interim President and CEO Paul Cataford, along with CFO Stephen Lemieux, will represent Titan Medical Inc. at the conference.
When is Titan Medical's presentation scheduled at the conference?
Titan Medical's presentation is scheduled for May 2, 2022, at 3:30 PM ET.
Where can I watch TMDI's presentation from the conference?
The presentation will be available via live webcast on Titan Medical's Investor Relations website.
What is the focus of Titan Medical Inc. regarding the Enos™ system?
Titan Medical Inc. is focused on enhancing robotic-assisted surgery and intends to initially pursue gynecologic surgical indications with the Enos™ system.
